Lymphoma Cancer Treatment

LYMPHOMA CANCER


What is Lymphoma Cancer?

Lymph is considered a part of the interstitial fluid, the fluid which lies in the interstices of all body tissues. Interstitial fluid becomes lymph when it enters a lymph capillary. The lymph then travels to at least one lymph node before emptying ultimately into the right or the left subclavian vein, where it mixes back with blood. Lymph returns protein and excess interstitial fluid to the circulation. Lymph picks up bacteria and brings them to lymph nodes to be destroyed. Metastatic cancer cells can also be transported via lymph. Lymph also transports fats from the digestive system.

Typically, lymphomas appear as a solid tumor of lymphoid cells. These malignant cells often originate in lymph nodes, appearing as an enlargement of the node (a tumor). It can also affect other organs in which case it is referred to as extranodal lymphoma. Extranodal sites include the skin, brain, bowels and bone.

There are two major types of lymphoma: Hodgkin's disease and non-Hodgkin lymphoma (NHL).

Risk Factors of Lymphoma Cancer

Epstein-Barr virus (EBV) DNA has been identified in tumor tissue from many of patients, indicating an important and early role for the virus in tumor development. The cause of Hodgkin’s disease remains unknown.

Symptoms of Lymphoma Cancer

Non-specific symptoms could be anorexia, dyspnea (shortness of breath), fatigue, fever of unknown origin, lymphadenopathy, night sweats, pruritus, and weight loss.

Treatment Options for Lymphoma Cancer at FROS Radiation Oncology Cyberknife Center:

At FROS Radiation Oncology Cyberknife Center, our team is committed to bringing leading-edge technology with highly compassionate care to our patients.

Please call us at 1-888-880-6646 today to find the right treatment for you.

 

 

Contribute!

LOCATIONS

Flushing: 40-22 Main St, 4th Fl,
Flushing, NY 11354
   
Brooklyn: 1737 Bath Ave
Brooklyn, NY 11214
   

STAY CONNECTED

Stay in touch with FROS Radiation Oncology & Cyberknife Centers. Join us on Facebook, Twitter and LinkedIn for latest news and info.